Ekso Bionics Holdings Inc
NASDAQ:EKSO
Ekso Bionics Holdings Inc
Total Equity
Ekso Bionics Holdings Inc
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
Total Equity
$14.1m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Equity
$25.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
17%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$19.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$19.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$38.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$14B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
See Also
What is Ekso Bionics Holdings Inc's Total Equity?
Total Equity
14.1m
USD
Based on the financial report for Mar 31, 2024, Ekso Bionics Holdings Inc's Total Equity amounts to 14.1m USD.
What is Ekso Bionics Holdings Inc's Total Equity growth rate?
Total Equity CAGR 5Y
25%
Over the last year, the Total Equity growth was -34%. The average annual Total Equity growth rates for Ekso Bionics Holdings Inc have been -30% over the past three years , 25% over the past five years .